Search headlines

EPFL will celebrate its Healthy Campus certification during its upcoming "Health Days"

EPFL (Ecole Polytechnique Fédérale de Lausanne) has received the FISU’s Healthy Campus label with the highest certification level—platinum. It earned a score of 99 out of 100 in recognition of its comprehensive commitment to health. EPFL has officially—and with honours—joined the ranks of universities that make the health of their community a daily priority. To […]

Sep 22 • 8:19 AM EDT • Health • fisu.net

Pacers’ Pascal Siakam Receives Harsh Label in New NBA Study

With the NBA preseason approaching, a new salary analysis has identified which players provided the strongest and weakest returns relative to their contracts last season. Indiana Pacers forward Pascal Siakam claimed the study’s most unforgiving distinction.Casino Guru USA ranked him as the NBA’s most overpaid player after comparing 2026-27 cap charges with production from the […] The post Pacers’ Pascal Siakam Receives Harsh Label in New NBA Study appeared first on HEAVY.

Sep 21 • 10:06 PM EDT • Sports • sports.yahoo.com

Our worst performance of the season

West Bromwich Albion defender Conor Townsend labels their Black Country derby 1-0 loss to Wolverhampton Wanderers their "worst performance of the season".

Sep 21 • 7:31 AM EDT • Sports • sports.yahoo.com

Suno made a new AI music model with major labels. Here's what it means

Record labels that sued AI music companies are now licensing them. But payouts are undisclosed, lawsuits continue and musicians ask who benefits.

Sep 21 • 6:00 AM EDT • Entertainment • latimes.com

Suki Waterhouse Announces December Tour Dates, Timed Close to Robert Pattinson's Next Blockbuster Release

The English singer's major-label debut album was released over the summer.

Sep 21 • 2:27 AM EDT • Entertainment • thestate.com

Suki Waterhouse Announces December Tour Dates, Timed Close to Robert Pattinson's Next Blockbuster Release

The English singer's major-label debut album was released over the summer.

Sep 21 • 2:27 AM EDT • Entertainment • macon.com

E-bikes: Unsafe or uncertain?

Most parents see benefits and risks of e-bikes for teens and pre-teens. Half of parents are unsure where e-bikes are supposed to be ridden. Parents strongly support helmet requirements, labeling of e-bike types, and better direction on where to ride. Only 1 in 10 parents support a ban on e-bikes.

Sep 20 • 11:06 PM EDT • Health • mottpoll.org

Frank Mrvan talks steel industry, possible Chicago Bears move

.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_becb4b5b400cc85a8142076459fad58a'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 208470 - Article: Frank Mrvan talks steel industry, possible Chicago Bears move'; var post_id = 208469; var post_url = "https://www.insideindianabusiness.com/videos/frank-mrvan-talks-steel-industry-possible-chicago-bears-move"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });

Sep 20 • 4:07 PM EDT • Business • insideindianabusiness.com

Fill your diary with October’s must-catch entertainment

From a mic-swallowing virtuoso, to the story of the first chatbot and Sidney Nolan’s Ned Kelly family reunited at last, there are plenty of reasons to leave the house.

Sep 20 • 3:00 PM EDT • Entertainment • afr.com

First pediatric medical-behavioral Health Unit opens, Deaconess partners with Evansville Fire Dept

.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_6a8e5afc39f852b50a5529c8e17c7b1e'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 208479 - Article: First pediatric medical-behavioral Health Unit opens, Deaconess partners with Evansville Fire Dept'; var post_id = 208543; var post_url = "https://www.insideindianabusiness.com/videos/first-pediatric-medical-behavioral-health-unit-opens-deaconess-partners-with-evansville-fire-dept"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });

Sep 20 • 12:30 PM EDT • Health • insideindianabusiness.com

FULL SHOW: Inside INdiana Business 9/20/26

.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_45da0acbd54312ee5199625a1d6c1696'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 208505 - Article: FULL SHOW: Inside INdiana Business 9/20/26'; var post_id = 208502; var post_url = "https://www.insideindianabusiness.com/videos/full-show-inside-indiana-business-9-20-26"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });

Sep 20 • 7:59 AM EDT • Business • insideindianabusiness.com

Science Vs on the 49ers Substation: Anatomy of a Hatchet Job

In August, Pablo Torre Finds Out and Science Vs released an episode about my theory that electromagnetic fields from the electrical substation beside the 49ers facility may be contributing to the team’s run of soft-tissue injuries. As the originator of the theory, I was also a subject of the episode. I sat was interviewed by Wendy Zukerman and Rose Rimler of Sciene Vs. I sent them research, connected them with scientists, and spent hours digging through the City of Santa Clara’s and Silicon Valley Power’s records to help clarify critical details. Both Wendy and Rose came off as affable and professional, showing curiosity during the interviews, with Wendy going out of her way to question the “conspiracy theory” framing itself. Then they titled the episode We Solve the 49ers Viral Conspiracy Theory. I was familiar enough with their catalog that I never expected them to agree with my theory, but I did expect them to give it a fair hearing and to deliver their findings honestly. On both counts they came up short. They were not directly dishonest in anything they said, but rather in what they left out, in how what remained was cut, and in the picture painted by those two things in combination. They asked me to recorded the interview on my phone for better audio quality, and I held on to my copy for reference later. That turned out to be a fortuitous decision. Here is the raw audio of my first interview, unedited*. Only my side was recorded, so their questions aren’t on it, but you can generally infer them from the answers, and every claim I make below about what I said can be checked against my statements in this clip. (Note: Wendy had connection trouble at the beginning of the interview and was cutting in and out, which accounts for the false starts.) 0:00 -1:19:13 Audio playback is not supported on your browser. Please upgrade. Science Vs is a fun show. It is pitched at roughly a high-school understanding of science, for an audience that is skeptical, Snopes-oriented, and worried about misinformation. Take a claim circulating online, interview a supporter of the claim, interview consensus scientists, and then tell people which side of the line it lands on. I have listened to their episodes on raw milk, seed oils, 5G and other contested issues in the wellness space. I have problems with all of them, but each at least made an honest attempt to represent the actual range of scientific opinion by talking to credentialed scientists with differing perspectives. Dissenting researchers were heard from, answered, and often given a chance to respond. This episode did not do that. This article is not a relitigation of the science. I have written extensively about that already. This post is for the record. It is simply an accounting of what was wrong with their episode. Contents Is there a power plant next to the 49ers practice facility? — the clearest single example of getting something objectively wrong For the record — a high-level overview of all of the problems with their investigation Draw your own conclusions — why they had to make this episode at all What they left out about childhood leukemia — the exposure threshold, and playing games with statistics to minimize sick children What they left out about the mechanism — the body of literature they refused to cover, and evidence for the mechanism used against it The scientists Science Vs interviewed and did not air — four credential scientists who support myhe theory, recorded and cut, or not even called How they misrepresented me and my case — an answer severed from its question, and three telling edits How you would actually study the injuries — it doesn’t actually matter which team is the most injured, overall The theory: magnetic fields, oxidative stress, and collagen Since the episode never states my theory, here it is below. Those who are familiar with my work can skip this section. Electrical equipment produces magnetic fields, and those fields induce faint electrical currents in anything that passes through them, including people. My argument goes further than induced current. Mitochondria — the structures that generate a cell’s energy — run on continuous flows of electrons and protons, and those flows carry faint electromagnetic fields of their own. Maxwell’s principle of superposition shows that when two fields share the same space, they add together. An external field does not need to be strong to alter an internal field, it only needs to be present. The electron transport chain inside the mitochondria leaks a small fraction of its electrons by design, and those become reactive oxygen species — free radicals, which healthy cells use as signals. External magnetic fields cause the rate of leakage to change, increasing free radicals. When free radicals accumulate faster than the cell’s antioxidant systems can clear them, the result is oxidative stress. Oxidative stress is a recognized driver of chronic illness, including cardiovascular disease, neurodegeneration, diabetes and cancer, and it is in every medical school curriculum. One of its ordinary effects in connective tissue is that it switches on matrix metalloproteinases — MMPs, the enzymes that break collagen apart — while suppressing new collagen synthesis. Tendons are made of collagen. An athlete loading his soft tissue heavily six days a week is already creating oxidative stress in the tendons, so the addition of magnetic field exposure compounds the damage and inhibits repair, making him more susceptible to injury when enormous force lands on a tendon in a fraction of a second. That is the theory. We know that EMF causes oxidative stress, and we know that oxidative stress degrades collagen. The only thing missing is a study showing that direct connection. I have never claimed certainty that the substation is contributing to the elevated injury rate. I do believe it is likely, and I believe it warrants caution, and that a revenue machine like a major NFL team can easily afford to remove the exposure out of precaution. Is there a power plant next to the 49ers practice facility? Here is the clearest single instance of the problem with this episode. It requires no knowledge of electromagnetic fields at all. This story first came to me through Jon Feliciano, a former 49er, in an interview on Willard & Dibs on 95.7 The Game. Asked about why the 49ers are always injured, he said players used to joke that it was the power plant behind the practice fields. Wendy Zukerman corrects him on air. “It’s important to say that it’s not a power plant near the 49ers site.” Torre then asks her to explain the difference between a substation and a power plant. Her answer: a power plant generates electricity and transmits it to a substation, which converts the voltage into something your house can use and sends it on to your home or your business. There are two problems with that. The first is that there is a power plant on that site. The Gianera Generating Station is a natural-gas-fired peaker plant owned by Silicon Valley Power, and it has been there since 1986. I have published aerial photographs of the location from 1987 in which the gas plant is the only thing standing, before the practice facility was even there. I even mentioned the gas plant in my first interview. (Feliciano has since gone on record about this issue, and it is clear he had the substation in mind rather than the gas plant.) The second is that her definition describes a distribution substation, and the facility beside the 49ers is not that. It is the Northern Receiving Station, which takes in bulk power from outside the city’s grid and delivers it to distribution substations. Silicon Valley Power’s own map distinguishes receiving stations from substations, and Rose Rimler even reads the label out loud in the episode when she walks through that map on air. A few minutes before the map segment, Zukerman tells Torre: “like I said, we fact check everything.” Well, maybe not everything. I made a mistake On the morning of July 6th, at 10:20, I sent Rose and Wendy two studies. During the interview I had been asked which human studies show oxidative stress from electromagnetic fields, and I had not been able to name one on the spot. Rose emailed asking for the studies, I quickly searched for a couple, and I wrote that I thought these were the most relevant from that search. Unfortunately, I was busy and did not read either one closely at first. I picked them because they were topically relevant — one on substation workers, one on power plant workers. Neither were great studies, and their problems go past the ones raised in the episode. That was careless on my part. There is context that did not make the episode, though. Before that email I had been on a Zoom call with Rose talking about EMF and oxidative stress, and I pointed her to Dr. Henry Lai at the University of Washington, who has spent years aggregating the literature on this question. His tallies show that roughly 90% of studies since the late 1990s find oxidative effects from electromagnetic field exposure — hundreds of studies, systematically counted. Rose told me she was already aware of his work. So when she asked for studies, I understood her to have the aggregate view already and that she would report anything within that context. Not reading those two carefully was still a mistake, but the larger mistake was assuming the episode would be based on a thorough review of the actual body of literature, rather than on whatever I happened to send that morning. The second email At 1:49 that same afternoon — three hours and twenty-nine minutes after the first — I sent them a second email that I had been preparing for a while. It was a structured document in six numbered sections, written in response to a request they had made two weeks earlier, laying out my entire argument with citations attached to every link in the chain. The episode aired on August 13th, five weeks later, and not a single item from the second email is in it. Here is how it opens: The full email is included at the bottom of this post in Appendix B. Nearly 1,500 words in total. It contains two named mechanisms with the physics behind them. Occupational studies in humans. The literature on oxidative stress and collagen. A section addressing the strongest counter-evidence against my own theory, which I raised myself. And a closing section stating plainly what the theory cannot yet show. My entire argument, in writing, with detailed citations for every claim, provided to them five weeks before broadcast, and none of it made it into the episode. That is the single largest omission, but it is not an isolated one. The whole episode is riddled with similar problems, and the conclusion they came to is not merely a difference of opinion about the scientific evidence. Through omission and through strategic editing, Science Vs misinformed its audience — about what the evidence shows, about what I argued, and about who they spoke to. That is a notable outcome for a show whose stated purpose is correcting misinformation. For the record I am not going to tell you that Science Vs set out to discredit me, or that they had come to their conclusion before they reported the story, or that they used misleading editing to make me look like a man retreating from his own theory. I cannot know what was in anyone’s head, and I am not going to pretend otherwise, either. What I can tell you is what is on the record. They asked me for evidence and aired the weakest thing I sent. They interviewed three scientists who supported my theory and aired none of them. They discussed childhood leukemia without ever saying the exposure level at which it appears. And they took an answer I gave weeks before Ken Karipidis, the one EMF scientist who was put on air, was interviewed, and placed it directly after his critique, where it comes off as a major concession. A friend of mine who has worked as a journalist for thirty years read that last one and called it sleazy. I agree with her. Those are just the four issues that are impossible to defend as pure editorial decision, but they are not the only issues. The most glaring issues stem from what they left out: The exposure level at which the childhood leukemia association actually appears — three to four milligauss, a number the episode never states despite it being much lower than what I measured. The mechanism itself: The episode gets as far as “oxidative stress could weaken collagen,” which leaves it sounding like speculation, rather than a known pathway. The second email, and all the studies in it. Dr. Paul Héroux at McGill, whose work my proposed mechanism rests on, whose contact details I supplied, and who was never called. Dr. Beatrice Golomb at UC San Diego, who runs a research group on oxidative stress and mitochondrial function and has specific expdertice in collagen, interviewed and not aired. Dr. David Carpenter at Albany, the most prominent academic voice on the harm from magnetic field exposure, interviewed and not aired. Dr. Joel Moskowitz at Berkeley, interviewed and not even credited. The specific, testable condition I put in writing that would make me abandon the theory. My own unprompted statement of the theory’s evidentiary gap. My caveats about my own measurements. My ranking of EMF as one factor among several rather than the only one. The new equipment installed at those facilities between 2010 and 2014, and the sharp rise in system load from 2013 onward. But that is not all. What they kept, they selectively edited to serve a narrative that was not served by the raw transcripts of the interviews. A description of thousands of commercial routers in a workplace, reduced to the Wi-Fi in your house. My own acknowledgment, multiple times, that "I'm not a scientist" clipped in an episode that spends considerable energy pointing out that I am not a scientist. And a qualification I volunteered about my own measurements, cut from my answer and delivered later by their EMF expert as a correction. Together their edit produce a portrait of a wellness guy with Wi-Fi phobia and two bad studies, backing away from his theory the moment a “real” scientist looked at it. A practice facility where nothing changed because no new substation was built. Injuries written off as random because the 49ers were not quite the single most injured team in the league over the period in question. That portrait is false even though almost no individual statement made in the episode is. Draw your own conclusions At the top of the episode, Pablo Torre says his show had been flooded with requests to investigate the substation — that it was the thing they were asked to look into over and over again. Neither show went hunting for this story. It arrived from their own audience, in volume, and it could not be waved off. A thread I posted on X reached twenty-two million people. A guy with a gaussmeter and a brand-new Substack obligated a Pultizer prize winning program to spend an hour on a question about player health, that is considered fringe enough that most media operations won’t touch it. Pablo Torre Finds Out could not ignore it. So Science Vs came in and ran a “debunking” operation instead of an investigation. Everything below is what had to be left on the cutting room floor to deliver the “debunking”. They could not ignore it. So they tried debunked it instead. The demand was strong enough to force an episode, and since the episodes release the 49ers have sustained more injuries, including season ending ones, and interest has only grown. Demand from fans and playets is strong enough to force a better investigation from someone else. An omission is not a lie until you find out what was omitted. What follows is the detailed record so you can see the full picture. Draw your own conclusions. I have drawn mine. I am going to keep publishing. A note about Pablo Torre Finds Out After the episode aired I posted publicly, calling out Pablo Torre Finds Out for concerns I had about the integrity of their investigation, and about an interview directly with Pablo Torre which had been offered but never happened. I have since spoken with a producer at PTFO. The offer had rested on a misunderstanding about where things stood between us, and it fell away as the Science Vs part of the production widened past the science. He apologized for the miscommunication and I accepted. The producer also confirmed to me that they did essentially hand off the entire investigation to Science Vs for narrative purposes — so Pablo would be genuinely curious or potentially surprised by their findings — while still taking responsibility for what went out under their name. I appreciated the candor and the accountability, and I am comfortable with where we left things. So this post is not about PTFO. My disagreement is with Science Vs. What they left out about childhood leukemia Childhood leukemia appears at three milligauss. They gave no number at all. 1. They built an EMF ruler, then discussed childhood cancer without it. The sequence on air went like this: First I measured almost 9 mG, then I measured up to 50 milligauss. Torre reacts with concern — “that sounds high.” Cut to Karipidis: the public limit is 2,000 milligauss. Torre reacts again — “What happens at 2,000?” Karipidis explains that nothing happens at 2,000, that safety factors are built in. Then: at more than 50,000 milligauss you get flickers of light in the retina, and higher still, nerve stimulation. The listener now has a ruler (their ruler) to measure these numbers with. Fifty is nothing by their ruler. Then the episode turns to childhood leukemia and states, accurately, that there is a real association — but tellingly, they never give the exposure level at which that association appears. Childhood leukemia appears at three milligauss. They conveniently left that out. The pooled analyses that produced the World Health Organization’s carcinogen classification found roughly a doubling of childhood leukemia risk above three to four milligauss. That is the number that belongs in that segment, and it is more than ten times below the reading that had just been dismissed as trivial. I gave them that number myself, on tape, in the interview. Describing my own threshold, I said my comfort level for long-term chronic exposure is three to four milligauss, but preferably one. 2. Six children in thirteen million. The episode reports that these fields might explain one to four percent of childhood leukemias, then reframes it as a German estimate of perhaps six cases among thirteen million children. Torre, to his credit, is uncomfortable. What never gets explained is why that number is small. Almost no children lives above three milligauss in Europe. Fewer than two children in a hundred, in the Italian data. So even if the risk to those children doubles, the number of additional cases across an entire country stays small — not because the hazard is small, but because hardly anyone is exposed to it. Count the whole population and the few who are exposed disappear. And the reason hardly anyone is exposed is that siting rules keep housing away from transmission lines. In Europe, at least. The Dutch government has a standing precautionary policy against building new homes in any zone where the annual average magnetic field exceeds 4 milligauss — the same number the episode never mentioned. Denmark and Norway treat 4 milligauss as the level that triggers a look at mitigation. That is five hundred times below the ICNIRP figure quoted on air. The United States has no federal equivalent. That is evidence of infrastructure siting policy working. It is not evidence that there is no hazard. It is evidence that we already act as though there is one. If you listen to the raw audio you will hear that my proposed solution is EMF exposure is to build better infrastructure. What they left out about the mechanism 3. They accused me of cherry-picking, and then cherry-picked themselves. On air, Zukerman tells Torre that people who worry about electromagnetic fields dismiss the studies showing null results and collect the ones showing harm, and that this is why you have to be careful not to cherry-pick. They had two papers I had rattled off in a hurry, and a second email containing a carefully chosen set. They ran the two weakest, graded them on air, and presented the result as the state of the evidence for not only my theory, but the whole question of oxidative stress from magnetic fields. That is cherry-picking from my emails. The bigger picture is what they did with the literature as a whole. Zukerman acknowledges it exists, dismisses it, and disposes of it in a single stroke. You can go online right now, she tells Torre, and find scores of studies showing these fields increase oxidative stress. The issue, she says, is that they are not studies in people. Many of them are in people. The occupational studies in my second email are in people. That email had been in her inbox for five weeks. She waved off the literature on a factual claim that the documents in her possession contradict. (I have written separately about the evidentiary standard at work here). The effect was that they essentially baited me: ask the subject to supply the evidence, take the weakest thing he sends, and let that stand as a proxy for the whole argument. Wendy has been doing this show for ten years and clearly knows how to extract what she needs for her desired narrative. 4. They presented the collagen-improvement research as a gotcha, but I had already addressed it. The episode treats the existence of studies showing that EMF can improve collagen as a surprise that undercuts me, but I had pre-emptively addressed that five weeks earlier in the email they ignored. Those studies use measured, high-intensity pulsed dosing. The mechanism by which they work is oxidative signalling. The cell reads a controlled rise in reactive oxygen species as a warning, upregulates its antioxidant defenses, mounts a repair response, and the therapy stops before the system is overwhelmed. The key point is that it induces an oxidative response, which means those studies are actually evidence for my proposed mechanism, not against it. A field that produces a therapeutic effect cannot be biologically inert (which is the implication when they say “Nothing happens at 2,000 milligauss). Chronic ambient exposure is the same pathway with no off switch, and it is most consequential during the evening and while sleeping, when the body is in repair mode and the exposure does not stop. Section 5 of my email is titled What about the study showing improved collagen synthesis. I raised the counter-evidence myself, explained why I did not think it refuted the theory, and wrote that I was disappointed the question had not come up in the interview. That is worth holding against the cherry-picking charge in the item above: the studies they presented as inconvenient for me were studies I had gone out of my way to put in front of them. 5. Section 1 of my email stated a critical argument that was never put to the expert directly responsible for it. My email says the exposure limits exist to prevent acute effects and do not address chronic exposure at all, and that my dispute is with the entire framework. Zukerman gestures at this once. After Karipidis gives the 2,000 milligauss figure, she tells Torre that I would object because those levels do not capture “more subtle effects.” That is not my argument, and “subtle” is doing a lot of work here. My argument is that the limits are built to prevent acute effects — nerves firing, muscles twitching, etc — and were not designed to address chronic exposure at all. In fact, ICNIRP’s own documents state as much themselves. Mine is a structural objection to what the standard measures, reduced as a concern about subtlety, it becomes a matter of degree, rather than a categorical difference. They interviewed Ken Karipidis, vice chair of ICNIRP — the body that writes those limits. He was asked what the limit is, but he was never asked how it applies to chronic exposure. The scientists Science Vs interviewed and did not air 6. They interviewed four officials of the standards body. The episode credits roughly a dozen researchers. Four of them are associated with ICNIRP. Ken Karipidis is the vice chair. Rodney Croft chaired ICNIRP from 2020 to 2024 and led the development of its current guidelines. Dan Baaken is ICNIRP’s scientific secretary. Frank de Vocht sits on the Main Commission. One of them speaks in the episode. Their institution’s position is more than adequately represented — the 2,000 milligauss figure, the safety factors, the assurance that nothing happens below the line. 7. The four who were left out. Dr. Beatrice Golomb is Professor of Medicine at UC San Diego — a physics undergraduate degree, a PhD in biology, an MD. She directs a research group whose stated focus is the relationship between oxidative stress, mitochondrial function and health. That is the mechanism the episode spent its first half dismissing. Her published work includes the fluoroquinolone case series behind the FDA’s black box warning on an antibiotic class that ruptures tendons, where the accepted mechanism is oxidative stress and mitochondrial toxicity — the back half of my chain, already on a drug label. She is in the credits. She is not in the episode. She has told me she finds my theory biologically plausible, and that she has a recording of her interview. Dr. David Carpenter directed the Institute for Health and the Environment at the University at Albany for decades and is the most prominent academic voice arguing these fields cause harm. Childhood leukemia is the reason these fields carry a WHO classification at all, and Carpenter is the person you call if you want that case made by someone who has spent a career on it. He is in the credits. He is not in the episode. He has told me that when he was interviewed they could not have been less interested in what he had to say. Dr. Joel Moskowitz directs the Center for Family and Community Health at UC Berkeley’s School of Public Health. He told me directly that they interviewed him and that he thought it went well. He does not appear in the episode, and unlike Golomb and Carpenter, he does not even appear in the credits. Dr. Paul Héroux at McGill is the researcher whose work provides the foundation for the oxidative stress mechanism my theory rests on. I gave Rose his email address and phone number. He was never interviewed. They never even called him. 8. “He’s not a scientist.” The episode leans hard on the fact that I am not a credentialed scientist. Zukerman says it. Torre repeats it. “At all.” Having built a segment on that, they then left out the physicist-biologist-physician, the professor of public health, the director of a university environmental health institute, and the McGill researcher whose work the primary mechanism comes from. They spent the episode telling their audience I am not a scientist, and then kept four actual scientists who support the theory off because their argument does not survive otherwise. How they misrepresented me and my case 9. They played my words as a response to an interview I had never heard. Near the end of the hour, Zukerman says she went to me and told me the evidence was lacking. Then she plays me saying I am not wedded to it being an EMF, that I have staked my reputation on it needing more study, and that I am not certain of anything. That segment was placed immediately after Karipidis had finished taking the cherry-picked papers apart. It plays as a man folding under expert scrutiny. Commenters have used it against me since, but it is incorrect. Here is the sequence as it happened. I was interviewed. Karipidis was interviewed weeks later. I was never told what he said, or even who he was. I was never asked to respond to it. I did not know his name until the episode aired. That is not a simple editing decision. That is a quote from one interview, moved to follow a critique from a different interview it was not a response to, so that it would land as a concession. A friend of mine who has spent thirty years as a journalist read that sequence and called it sleazy. She is right. The full passage is reproduced in Appendix A, and it is worth reading. What airs is the preamble. Four paragraphs later I say “to directly answer your question” — and that answer, about what would change my mind if the team relocated, is not in the episode. Neither is the sentence two paragraphs on, where I say the EMF might turn out to be ten percent of the problem. I will say the underlying point again, though, because I meant it and I still do. I am not wedded to my theory that magnetic fields from the substation are contributing to the 49ers injuries. I could be wrong. What I am wedded to is the process of scientific inquiry, and the fact that we should be cautious around these exposures and we need more independently funded studies. 10. Three telling edits. They cut “I’m not a scientist” mid-sentence. What I said: “...and I am not certain of anything. I’m not a scientist. To me, I find the mechanisms compelling. I will go back to the fact that I got into this not because of the 49ers, but because of clients I was working with who suffer from EDS...” What aired: “...and that I am not certain of anything. I’m not.” The clip ends on the first two words of the sentence in which I say I am not a scientist, in an episode that spends considerable energy establishing that I am not a scientist. The full sequence is in Appendix A. They cut my own description of my work. Asked what I do, I said I run a wellness business, that I am focused on writing software to help people navigate environmental stressors, that environmental health is my focus, and that I also do independent journalism and research. What aired is the wellness business and the environmental health, with the software and the journalism removed from my own answer. The software engineering does come up later — narrated by them, as a hacker who grew up to write firmware — but my current work, in my own words, arrives as “wellness guy.” Thousands of commercial routers became home Wi-Fi. What I described: working at a wireless networking company surrounded by thousands of Wi-Fi routers, and a stress-induced health collapse afterward that working in that environment contributed to. What aired: Wi-Fi, the kind you have at home — reinforced by a clip of Christian McCaffrey talking about turning his router off at night. Three cuts, and every one of them makes me seem less credible. That is not a coincidence. 11. I gave them my own caveats and the test that would disprove me. In the first email I wrote that a well-designed chronic, ambient-level exposure study in tendon showing no collagen degradation, run over many months, would undercut my confidence in the theory. That is a specific, testable condition, stated in advance and in writing. There was a second interview, weeks later, which was not used in the episode, but in that I asked again for the falsification criterion to be included. What the episode presents instead is a man saying “we need more study,” which reads as a hedge, an open-ended request for the benefit of the doubt. It is the opposite of a hedge. Section 6 of my second email says, unprompted, that as far as I am aware there is not a single study showing EMF-driven oxidative stress degrading collagen in a human in vivo or in human tendon in a lab. I wrote that because it is true and because it is the first thing anyone should check. Under their standard it becomes the hinge of the entire first half, framed as something they had to surface without my cooperation. I had handed it to them five weeks earlier. And in the interview I said that my 25 to 50 milligauss readings were taken at knee level, and that these fields attenuate quickly, so by the time it reaches your head it is not that high anymore. That did not air either. The qualification arrives later, from Karipidis, as a correction. How you would actually study the injuries 12. They measured the wrong thing. The episode spends its final act on whether the 49ers are the most injured team in the NFL, finds no clean ranking, and lands on “injuries are random”. That is the wrong test. You would define the exposure — measured field levels at the facility — and the outcome narrowly: soft-tissue injuries, not a single MSK injury count that a broken finger and a ruptured Achilles both land in. Then you would compare the 49ers to themselves before and after the exposure changed, and compare that change against every other team over the same window. That controls for league-wide shifts in rules, turf and training load. It is a difference-in-differences design, and it is standard. I sent them that argument on July 28th, in writing, along with the fact that in eleven of the past twelve seasons the 49ers had finished top ten in Adjusted Games Lost. And by the episode’s own reporting, the 49ers are second in games lost to injury over the past decade, with FTN’s Aaron Schatz confirming that once you adjust for starters they come out second worst in the league — after having been one of the healthiest teams for years before that. A finding like that is where an investigation starts, not where it stops. 13. I did a lot of substation research for the episode that was never aired. I had reported that the substation next to the facility was expanded in 2014. That was wrong, and Rose Rimler and I sorted it out together. They gave me credit on air, which I appreciated, but framed it as a concession on my part to something they had found. In fact I had been investigating it myself, was uncertain before they asked, but was waiting for clarification from Silicon Valley Power. The uncertainty centered around a substation named “Esparanca” that was proposed right behind the facilities as part of the stadium construction, but now appears to never have been built. I spent days in Silicon Valley Power’s records, and did eventually reach Silicon Valley Power for confirmation and indentified the mistake myself. I also gave them highly detailed documents on what we do know about those facilities: new equipment installed between 2010 and 2014, and load growth across the system with an inflection around 2013–2014, with the Northern Receiving Station carrying the highest capacity in the system and sitting closest to the data center corridor. None of that is in the episode. I have a separate piece about it coming out soon. *I cut 2 seconds from the raw audio to remove personal information that had no connection to anything in the episode. Appendix A: the passage the clip was taken from This is the sequence from my first interview, in full. The episode uses one fragment of it. It’s tricky because my understanding is that there’s something like a 15-year half-life on collagen remodeling issues. They’re going to get a new crop of players. What I really need, though, is for the injuries to be broken down so we can see the soft tissue injuries. Right now, they’re categorized as MSK injuries, but let’s say we can actually identify them more specifically. Is that right? He was able to do that? Oh, cool. I wasn’t able to find that information. Interesting — I didn’t know that data existed. I tried so hard to get it, and I didn’t know it was available. Maybe you could connect me with that person. That would be amazing. I’m not wedded to it being an EMF, honestly. I’m not. I would say that, to a certain extent, I’ve staked my reputation on the fact that it needs more study. It’s important to look into it, and I am not certain of anything. I’m not a scientist. To me, I find the mechanisms compelling. I will go back to the fact that I got into this not because of the 49ers, but because of clients I was working with who suffer from EDS, Ehlers-Danlos Syndrome, a tendon hypermobility issue. This condition is documented to be partially caused by oxidative stress. I’ve worked with them to mitigate their EMF exposure and have seen people improve. I think it’s a bigger story. In a way, the 49ers represent an occupational cluster with specific exposure risks. If someone would conduct a study on this, I believe we could learn a lot. Perhaps we would discover that it’s like, okay, maybe it’s 10% of the problem. I don’t know the exact number, but I think either way, conducting the study would provide valuable insights. To directly answer your question, it’s challenging for me because it’s part of a bigger story. If the 49ers move and stop having injuries, I might conclude that it was related to the substation. However, if they move and still experience injuries, I would want to analyze the nature of those injuries. Are they primarily soft tissue injuries? I don’t think it’s necessarily a case closed, but the story might lose traction at that point regardless. Three things are worth noting. The aired fragment stops immediately before the sentence in which I say I am not a scientist — the cut described in item 10. It also stops four paragraphs before the words “to directly answer your question.” What the episode plays is the throat-clearing. The actual answer, about what would change my mind, never airs. And two paragraphs in, I say the EMF might turn out to be ten percent of the problem. That is the ranking the episode says I never gave. Appendix B: the full email, July 6th, 1:39 PM Hi Rose, You asked me to send you some studies a couple of weeks ago. I apologize for the delay. I have been incredibly busy. I also wanted to give you a chance to dig in yourself, and get your own perspective before I influenced you too much with mine. That said, I do want to make sure that the actual argument is abundantly clear, so here it is! One note before I begin, there are really two separate questions here: Does the substation cause the soft-tissue injuries? That was my specific claim, and what the podcast is about. Is the theory biologically sound? Can 50/60 Hz fields at these levels do anything biological below the safety limits? Question two is why people have been calling me a conspiracy theorist. The regulatory and advisory bodies (ICNIRP, etc) maintain that anything below their exposure limits is biologically inert, and that position is broadly accepted within the mainstream, but the actual science paints a different picture. To defend my theory I’ve had to defend a much larger claim: that the advisory bodies have the biology wrong. I can’t honestly answer question 1 without first addressing that. Here’s is a simplified outline of my theory, with links to studies: 1. Advisory body thresholds for biological effects The ELF magnetic-field limits (ICNIRP’s ~2,000 mG public / 10,000 mG occupational) exist to prevent acute effects from exposure. If a magnetic field is strong enough, it makes nerves fire and muscles contract. Muscles twitch. You can see faint flashes of light in your vision. People can even feel tingling or even a shock. That happens due to Faraday’s law, which states that a time-varying magnetic field induces an electric field inside the body via the creation of Eddy currents.The standards assume that those currents do nothing below the twitch threshold. They do not consider chronic effects at all. My argument is that they are biologically active and do have chronic effects. 2. There are multipe ELF-EMF mechanisms for inducing oxidative stress. This is basic biophysics. Below are the two primary mechanisms. Simplest first. Dr. Paul Héroux of McGill has the most intuitive explanation, which rests on Maxwell’s principle of superposition: because Maxwell’s equations are linear, two sets of electromagnetic waves sharing the same space simply add together. In the interview I pictured a pebble dropped into a pond, sending out clean ripples. Then a boat motors past at distance, sending larger waves, and where they meet the ripples, the two add together and the original pattern gets distorted. In our cells, the mitochondria run on continuous currents of electrons and protons that carry their own faint electromagnetic fields. An external field from a substation, by the principle of superposition, adds to those internal currents and shifts the pattern. The electron transport chain in the mitochondria leaks a fraction of its electrons by design as reactive oxygen species (ROS), which act as signalling molecules in a healthy cell. Distorting that field increases that electron leakage, creating oxidative stress. A tiny electromagnetic interference results in a large downstream effect. https://www.sciencedirect.com/science/article/pii/S2405844025006474 The more complex pathway is Dimitris Panagopoulos’s Ion Forced-Oscillation / Voltage-Gated Ion Channel (IFO-VGIC) mechanism. Weak, polarized, low-frequency fields force the ions (calcium, potassium, sodium) next to an ion channel’s voltage sensor to oscillate; because that force scales with the inverse cube of the distance involved, fields far below the stimulation threshold can still force the channel open, disrupting the cell’s ion balance and driving ROS overproduction (Nitric oxide and superoxide interact and produce peroxynitrite, a highly unstable cytotoxin that breaks down into free radicals). https://www.researchgate.net/publication/366088934 https://www.spandidos-publications.com/ijo/59/5/92 https://www.mdpi.com/1422-0067/22/18/10041 https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1585441/full https://pmc.ncbi.nlm.nih.gov/articles/PMC3772193/ 3. Evidence of oxidative stress, in vivo, in humans from ELF-EMF There are many studies, and the strongest are occupational, which applies to the 49ers situation. 115 power-plant workers vs. 145 office controls. Serum malondialdehyde (MDA, the standard lipid-peroxidation marker), superoxide dismutase, and catalase were all significantly higher in the exposed group, and the markers rose with increasing field exposure. https://journals.sagepub.com/doi/abs/10.3233/WOR-203244 A follow-up where they reversed the oxidative stress in power plant workers. A double-blind randomized controlled trial: 91 power-plant workers given vitamin E, vitamin C, both, or placebo for 90 days. The antioxidant groups showed reduced lipid peroxidation and raised antioxidant capacity versus controls. https://pubmed.ncbi.nlm.nih.gov/32191586/ A spot-welder study: 46 welders occupationally exposed at 50 Hz, showed significantly altered red-blood-cell antioxidant enzyme activity and concluded ELF-MF “might act as an oxidative stressor… even at the recommended levels of exposure.” https://pubmed.ncbi.nlm.nih.gov/18504600/ A substation-specific study found oxidative stress and DNA damage https://pubmed.ncbi.nlm.nih.gov/24460415/ 4. Oxidative stress degrades collagen This half isn’t controversial at all. Oxidative stress activates the matrix metalloproteinases (MMPs) that break collagen down and suppresses its synthesis. Here are three example studies: Siwik et al. 2001: Oxidative stress raises MMPs and lowers collagen synthesis in cardiac fibroblasts. https://pubmed.ncbi.nlm.nih.gov/11121376/ Fisher et al. 2009: Collagen fragmentation drives oxidative stress and elevates MMP-1 in aged human skin. https://pmc.ncbi.nlm.nih.gov/articles/PMC2631323/ Varani et al. 2006: Decreased collagen production in oxidatively aged skin. https://pubmed.ncbi.nlm.nih.gov/16723701/ 5. What about the study showing improved collagen synthesis I’m glad you asked this question, and I’m bummed we didn’t get to it in the interview because it is a great question, and very important to understand. Superficially it may appear to be a refutation of my theory, but I would argue that it actually supports the underlying argument. That study used a short, high-intensity pulsed dose: therapeutic-PEMF, the same type of field used clinically to stimulate bone and tissue healing. The reason this works is because it triggers the very same biological pathways that can lead to oxidative stress. The exposure still stimulates ROS production, but done at a controlled dosage, for a limited duration it has a different effect. The cell reads the ROS as a warning signal and it upregulates its antioxidant defenses, and mounts a repair/proliferation response. The therapy is then stopped before the cell gets overwhelmed. That is essentially a hormetic response: a small dose of a stressor producing a beneficial adaptation. Two things follow: At the very least, this means the field is biologically active, which by itself undercuts the regulatory claim that these fields are inert below their thresholds. There is a wealth of literature on PEMF (pulsed EMF) bone regeneration and calcium channel signalling (which is the second mechanims in section one). Here is one. https://www.nature.com/articles/srep13856 At best, it leads us straight to my actual concern, which is that under chronic, chaotic and unregulated exposure, the cell’s antioxidant capacity gets overwhelmed, resulting in oxidative stress. There are plentiful examples of things that are beneficial at controlled doses, but harmful at uncontrolled doses. Excecise is one obvious, uncontroversial example. Botox is perhaps a more interesting example. 6. What about a study that shows EMF causing collagen degradation in humans? As far as I am aware there is not a single study showing EMF-driven oxidative stress degrading collagen in a human, in vivo, or in human tendon in a lab. There are studies involving isolated fibroblasts though, which secrete collagen. The most relevant one showed that human fetal scleral fibroblasts exposed to 50 Hz ELF-EMF showed a significant decrease in collagen synthesis and that MMP-2 expression was upregulated, which is the exact mechanism I described in section 2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3626379/ That’s it! Thanks again for the interview. Best, Peter Anthony Cowan Environmental Health · Wellness Tech · Researcher & Journalist Publisher & Editor, Living Energy Bio: petercowan.comSocial: X · Instagram · TikTokApp: sunlightis.lifePhone: [redacted]

Sep 19 • 6:34 AM EDT • Science • peteranthonycowan.substack.com

2026 Outstanding Women in Business Event Photos

The 2026 Outstanding Women in Business event was held on September 15, 2026, at LaBelle Winery in Derry.

Sep 17 • 2:59 PM EDT • Business • nhbr.com

Opinion | This Is Why So Many Voters Hate Both Parties

Most voters have messier views than their partisan labels would suggest.

Sep 17 • 5:05 AM EDT • Politics • nytimes.com

This White-Label Business Platform Is Just $399—Build, Market, Bill, and Manage Clients from One Place

Build and manage up to 10 websites with ease.

Sep 16 • 4:47 PM EDT • Business • entrepreneur.com

Canada keeps ‘associate membership’ label at arm’s length

'We're really much more focused on getting concrete results,' said the Canadian EU-envoy

Sep 16 • 9:35 AM EDT • Politics • euractiv.com

The public health insurance option isn't the great choice you think it is

Moderate Democrats have frequently been returning to an old Obamacare debate-era proposal called the public option. They often label it “Medicare for all who want it” in order to piggyback off the better known single-payer proposal. Those who desire reform but get anxious about a universal and single-payer insurance system dubbed “Medicare for All” understandably […]

Sep 16 • 7:00 AM EDT • Health • minnesotareformer.com

Trackonomy Completes Acquisition of Identiv's IoT Business, Building the Industry's Only Silicon-to-Cloud Physical AI Group

/PRNewswire/ -- Trackonomy Systems, the Physical AI company, today announced that it has completed the acquisition of Identiv's IoT label business. The...

Sep 16 • 6:12 AM EDT • Business • prnewswire.com

Why SCOTUS Protecting Mail-in Ballots Guards Trans Voting Rights

The changes proposed via executive order would have restricted mail-in voting across the U.S.

Sep 15 • 1:55 PM EDT • Politics • them.us

Ja’Marr Chase concern labeled big NFL Week 1 overreaction

Ja’Marr Chase had a quiet season opener for the Bengals, but one NFL analyst says there is little reason for concern.

Sep 15 • 11:30 AM EDT • Sports • sports.yahoo.com

‘Alligator Alcatraz’ put detainees in metal cages labeled ‘calming areas,’ watchdog finds

Nearly 80 immigrant detainees who were held at Florida’s makeshift detention center, known as Alligator Alcatraz, were briefly held in small metal enclosures for “periods ranging from several minutes to nearly 2 hours,” according to a federal watchdog report

Sep 14 • 11:21 AM EDT • Politics • cnn.com

Catherine Zeta-Jones slams the term 'nepo baby' as 'horrific'

Catherine Zeta-Jones is not a fan of the label "nepo baby." In fact, she loathes it.

Sep 14 • 10:52 AM EDT • Entertainment • centraloregondaily.com

Former NBA Champion Discredits New Miami Heat's Giannis Antetokounmpo Skills

Channing Frye sparks debate by labeling the multi-time MVP a physical "running back" lacking technical finesse, reigniting the rivalry between pure athleticism and versatile shot-making dominance.

Sep 13 • 12:00 PM EDT • Sports • sports.yahoo.com

Marian U. President discusses Crossroads Academic Medical Institute

.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_39437ed8a825372988ddac5e69036cd8'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 208183 - Article: Marian U. President discusses Crossroads Academic Medical Institute'; var post_id = 208180; var post_url = "https://www.insideindianabusiness.com/videos/marian-u-president-discusses-crossroads-academic-medical-institute"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });

Sep 13 • 10:30 AM EDT • Business • insideindianabusiness.com

FULL SHOW: Inside INdiana Business 9/13/26

.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_4e11a4d0c32548e609e933dd829bdcbb'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 208173 - Article: FULL SHOW: Inside INdiana Business 9/13/26'; var post_id = 208172; var post_url = "https://www.insideindianabusiness.com/videos/full-show-inside-indiana-business-9-13-26"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });

Sep 13 • 7:47 AM EDT • Business • insideindianabusiness.com

Nets Labeled as ‘Noncompetitive Without Own Pick’ in 2025-26

With Houston controlling their draft fate, Brooklyn pivots toward a veteran-led push for the Play-In, betting on Julius Randle and new depth to defy low expectations.

Sep 12 • 10:15 AM EDT • Sports • sports.yahoo.com

Canadian boycott of US products pushes grocers to adapt, explore new supply sources

A growing consumer push to buy Canadian and boycott U.S. products is reshaping supermarket shelves in Canada, forcing grocers to improve country-of-origin ​labeling and secure new sources of supply.

Sep 12 • 6:03 AM EDT • Business • reuters.com

Gillian Anderson comes out as pansexual, reveals relationships with women

Gillian Anderson is ready to put a label on her sexuality.

Sep 11 • 7:17 PM EDT • Entertainment • centraloregondaily.com

Barcelona star labelled ‘the Lamine Yamal of defenders’

Barcelona sporting director Deco has this week made known his appreciation for the talents of Blaugrana starlet Pau Cubarsí. This of course comes fresh off a spectacular last few months for the young...

Sep 11 • 4:20 PM EDT • Sports • sports.yahoo.com

What Today's Business Grants Reveal About Tomorrow's Funding Opportunities

Colorful GrantWatch promotional graphic featuring a winding road leading toward a bright city skyline at sunrise. A large white arrow on the road points toward “Tomorrow’s Opportunities.” On the left, a signpost displays funding focus areas including Innovation, Clean Energy, Workforce Development, Community Growth, and Small Business. The headline reads, “What Today’s Business Grants Reveal About Tomorrow’s Funding Opportunities.” The GrantWatch logo and “Time to Apply” appear at the top. In the lower right corner, a stack of books labeled “Plans” and “Grants” is topped by The Queen of Grants 2 by Libby Hikind, reinforcing the theme of planning for future grant funding opportunities.

Sep 11 • 10:49 AM EDT • Business • grantwatch.com

Barcelona label double Ballon d’Or snub ‘a worldwide scandal’

Barcelona sporting director Deco has this week made public the collective disbelief at the club regarding the exclusion of Blaugrana pair Raphinha and Pedri from the Ballon d’Or shortlist.The subjec...

Sep 10 • 5:25 PM EDT • Sports • sports.yahoo.com

Can a Live Nation-backed Atlanta label be a musician’s ‘reset?’ This exec thinks so.

Music executive Kei Henderson, who formerly served as 21 Savage's manager, started Third & Hayden to help boost musical artists' careers while maintaining their mental health.

Sep 10 • 3:51 PM EDT • Entertainment • ajc.com

Israeli legislative election and Netanyahu's politics of enmity

Rather than labeling his domestic rivals as outright traitors, Netanyahu frames them as the vehicles that will deliver the enemy's desired outcome. This deliberately blurs the line between legitimate political dissent and national betrayal | Anadolu

Sep 10 • 1:17 PM EDT • Politics • aa.com.tr

Apple Reveals iPhone 18 Pro and iPhone 18 Pro Max Battery Capacities

Apple has confirmed the battery capacities for the iPhone 18 Pro and iPhone 18 Pro Max models that the company announced earlier today. Apple is required to publish energy labels on its iPhone product pages in the EU, and they reveal the official mAh battery capacities for the devices. Here are the battery capacities for the iPhone 18 Pro and iPhone 18 Pro Max models that still have a SIM card tray, according to Apple: iPhone 18 Pro: 4,056 mAh (+1.7% vs.

Sep 9 • 4:56 PM EDT • Technology • macrumors.com

NASA’s Chandra Unveils Mysterious X-Ray Objects

Using NASA’s Chandra X-ray Observatory, scientists have discovered a new class of objects behaving unlike any they have seen before. Astronomers suggest these

Sep 9 • 2:11 PM EDT • Science • science.nasa.gov

T-Pain sues Akon’s record label, claiming he’s owed nearly $500K in royalties

The singer alleges Konvict Entertainment failed to pay his full share of royalties from recent music sales.

Sep 9 • 12:50 PM EDT • Entertainment • thegrio.com

Thunder Road, Lit Entertainment Launch New Banner

Basil Iwanyk and Erica Lee's film label and Adam Kolbrenner's management-production firm are teaming to create a new banner, TR/AK.

Sep 9 • 12:15 PM EDT • Entertainment • hollywoodreporter.com

Baton Rouge General's Health Tip of the Week: Another sugar substitute raises heart concerns

Sponsored by Baton Rouge General Cutting back on sugar? Take a peek at the ingredient label before reaching for a sugar-free treat. Recent research has raised questions about xylitol, a sugar alcohol found in products like gum, candy and baked goods. Higher blood levels of xylitol were linked to a greater risk of heart attack […]

Sep 9 • 2:01 AM EDT • Health • businessreport.com

ChatGPT Sketch turns your bad drawings into detailed AI images

Prompt with a scribble.

Sep 8 • 4:16 PM EDT • Technology • theverge.com

AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD

With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.

Sep 8 • 10:50 AM EDT • Science • fiercebiotech.com

Colombia business association labels hydrogen a $20bn ‘investment opportunity’

The National Business Association of Colombia (ANDI) believes the country’s hydrogen sector is an “investment opportunity worth over $20bn,” saying a pipeline of announced projects could attract enormous capital.

Sep 8 • 6:20 AM EDT • Business • gasworld.com

T-Pain sues Akon’s record label, claiming unpaid royalties

Atlanta rapper T-Pain is suing Konvict Entertainment, the record label co-founded in Georgia by singer Akon, claiming almost $500,000 in unpaid royalties from music sales.

Sep 8 • 5:00 AM EDT • Entertainment • ajc.com

Bengals’ Al Golden Makes Bold Claim About Rookie Cashius Howell

The defensive coordinator is already labeling the rookie speed rusher a home run after he stunned veterans in camp, signaling a potential shift in Cincinnati’s defensive hierarchy.

Sep 7 • 6:58 PM EDT • Sports • sports.yahoo.com

Warren County’s ‘other’ party says political labels mean less and less

Looking at the political history of Warren County, one could be forgiven for thinking anyone other than Republicans voted there. It’s been four years since anyone with a ‘D’ next to their name ran for a countywide office, and decades since a Democrat held a county position.

Sep 7 • 4:00 AM EDT • Politics • daytondailynews.com

Indian health activists lodge concerns about food warning proposal in court

Indian activists spearheading calls for food labelling said a government proposal to ‌have red warnings only when two concerning nutrients are high created an "industry-friendly loophole" disregarding public health, marking the first formal court objection to the plan.

Sep 7 • 2:54 AM EDT • Health • reuters.com

Indian health activists lodge concerns about food warning proposal in court

By Aditya Kalra NEW DELHI, Sept 7 (Reuters) - Indian activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created an "industry-friendly loophole" disregarding public...

Sep 7 • 2:53 AM EDT • Health • wtvbam.com

Indian health activists lodge concerns about food warning proposal in court

By Aditya KalraIndian activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created an "industry-friendly loophole" disregarding public health, marking the first formal court objection to the plan.India's proposal…

Sep 7 • 2:50 AM EDT • Health • tradingview.com

The science behind the beauty business

Some of Europe’s industrial champions may be in retreat, but its cosmetics sector remains a global leader, buoyed by healthy demand, recognised brands and a reputation for innovation."The fact is, the science in cosmetics is better here in Europe than anywhere else in the world,” says Pierre Morvan, CEO of Technature, a private label cosmetics manufacturer located near Brest in France’s northwestern Brittany region. “You have to have good science in order to make the difference, and that is why we invest so much in research and innovation.”Across Europe, the beauty and skincare products sector supports an estimated 3.6 million jobs, including 265,000 employed directly in the industry, according to the Cosmetics Europe trade group.. Cosmetics production contributes an estimated €11 billion to the EU economy, and generated €30 billion in export revenue last year, a €400 million rise from 2024.Technature itself has a global footprint, supplying products for 1,500 brands in 65 countries. Its range of skin gels, facial masks, nail treatments and other products include natural ingredients and extracts derived from plants, such as seaweed, that are developed and refined through science-based analysis and testing.While industry projections point to sustained growth for the foreseeable future, driven by emerging economies and wider availability of exclusive brands that were once chiefly sold by high street retailers, the sector is not immune to the impact of geopolitics and trade wars. The Trump Administration’s tariff threats have dented cosmetics exports to the EU industry's largest overseas market. After the European Parliament approved the EU-US Turnberry Agreement in June, setting a 15% levy on many EU goods, the French Federation of Beauty Companies warned that “exports are falling sharply” and urged the EU to negotiate an opt-out for cosmetics.Technature’s CEO flags South Korea as an emerging competitor, partly due to its assertive marketing efforts. “I would have to say I am a little bit scared,” Morvan says, regarding the growth potential of the South Korean cosmetics industry. “This is why science and innovation are so important if Europe is to remain the leader.”With a workforce of 200, including biologists, chemists and other scientists, around 15% of Technature’s staff work in three research and development (R&D) labs. A similar number work in four quality control and assurance facilities, where science plays a crucial in ensuring product safety in a sector that is subject to the European Cosmetics Regulation.Educational exchange between industry and academiaIn recognition of Technature’s research and innovation, Morvan was selected as one of Brest’s ambassadors to Science Comes to Town (SCTT), a European initiative to strengthen communications and understanding between science and society. Brest is one of three coastal cities in the EU-funded programme, alongside Split (in Croatia) and Kiel (in Germany). From 7-11 September, Brest will host the EU TalentOn contest featuring 100 early-career researchers from across Europe.Morvan appreciates the value of engagement with educational and scientific institutions as well as the home community. For instance, Technature collaborates closely with university partners to enhance its in-house R&D. In addition, it invites students to its labs and sends its own researchers to local institutions. "We absolutely want the students to know what the industry is all about,” Morvan says, noting that seeing science in action can help young people “understand that they can do something real with science, to create something with what they are learning.” He says another important benefit: encouraging new generations of young people to consider a career in cosmetics.Community involvement also raises awareness about Technature and the skincare industry as a whole. “The public gains recognition of the innovative company that we are, and this is important for getting new customers,” Morvan says. One of its recent innovations — tiny, colourful cosmetic pearls that release skin moisturisers on application — was showcased at this year’s VivaTech event in Paris.Morvan holds a master's degree from the Brest Business School and studied animal production and biology in Brest at the University of Western Brittany (UBO), an SCTT partner, and at the University of Tours. He got his start in business in 2002, initially working on using seaweed as a raw material in the food industry before transitioning to cosmetics. Morvan has always been interested in connecting science and business, reflecting one the goals of SCTT to enhance public-private collaboration.The invitation to participate in SCTT was unexpected. “It was a surprise to get a call from the city of Brest saying that they wanted me on this programme,” Morvan recalls, adding that officials were drawn by his company’s R&D. “It's not only theory and science fundamentals. Our science is something that is applicable to the global market — and important for the community.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.

Sep 6 • 8:00 PM EDT • Science • sciencebusiness.net

China’s $25b microdrama industry faces AI upheaval

The country’s wildly popular microdrama industry is undergoing a dramatic upheaval thanks to artificial intelligence – with a very real human cost.

Sep 6 • 2:00 AM EDT • Entertainment • afr.com

LeBron James Joins Polymarket as Prediction Markets Court Sports' Biggest Stars: Here's What We Know

On Saturday, four-time NBA champion and four-time Olympic medalist LeBron James announced an upcoming partnership with Polymarket, the prediction market platform. James posted a 14-second video on X showing him exiting an elevator at “Polymarket HQ,” with floor buttons labeled...

Sep 5 • 11:07 PM EDT • Sports • sports.yahoo.com

Trump says Iran conflict, which has killed 18 US service members and injured hundreds more, is ‘small potatoes’

President Donald Trump on Friday labeled the Iran war “small potatoes,” the latest attempt to minimize a six-month conflict that caused a spike in gas prices and led to the deaths of 18 American service-members.

Sep 4 • 3:07 PM EDT • Politics • cnn.com

Abdul El-Sayed is the latest Muslim candidate to labeled an anti-American extremist.

The bigoted rhetoric against Muslim American politicians is backfiring

Sep 3 • 3:22 PM EDT • Politics • latimes.com

Decagon on Saturn’s South Pole (Single Filter)

A single filter from NASA’s Hubble Space Telescope distinctly shows a 10-sided wave encircling Saturn’s south pole, labeled “decagon”.An “X” denotes where data was not captured.

Sep 2 • 2:00 PM EDT • Science • science.nasa.gov

Inside the gutsy, defiant Lucas Museum of Narrative Art

By discarding artistic hierarchy of any kind, the Lucas Museum of Narrative Art is stepping into an ongoing debate about what kind of work gets to be labeled "art."

Sep 2 • 1:00 PM EDT • Entertainment • latimes.com

Dem megadonor among 400 Jewish Michiganders labeled AIPAC insiders for denouncing El-Sayed's leftist campaign

Over 400 Michigan Jewish Democrats signed a letter backing Mike Rogers, but former Rep. Andy Levin claims AIPAC is really driving the effort.

Sep 2 • 9:26 AM EDT • Politics • foxnews.com

AMC Theatres Gets Into Distribution Business, Launches Leawood Films

AMC Theatres, the world's largest exhibitor, is getting into the distribution business launching Leawood Films, a label for small and mid-sized films.

Aug 31 • 4:30 PM EDT • Business • deadline.com

Instagram puts new limits on undisclosed AI profiles

As frustration over AI influencers has been growing, Instagram is limiting the reach of undisclosed AI profiles.

Aug 31 • 3:16 PM EDT • Technology • techcrunch.com

Google is getting flak for changing Lake Ontario name to Lake America

Canadian politicians are also scrubbing government websites that embed Google Maps to ensure the lake is labeled Lake Ontario.

Aug 31 • 1:02 AM EDT • Business • businessinsider.com

Four popular supplements that science says don't deliver

Walk into the supplement aisle and you’ll find plenty of products promising better health. But sometimes, basic chemistry and biology tell us those claims simply don’t add up. Before spending money on the next supplement promising better memory, faster recovery, or improved health, look beyond the label and examine the evidence.

Aug 31 • 12:00 AM EDT • Science • acsh.org

Star Entertainment (ASX SGR) casino operator reports $307.3 million loss

The casino and hotel giant is separately facing a fine of $400 million next month for anti-money laundering failures, putting more pressure on finances.

Aug 30 • 9:20 PM EDT • Entertainment • afr.com

Jelly Roll explains political beliefs after Trump roasts: I’m ‘down the middle’

Jelly Roll, whose real name is Jason DeFord, made jokes throughout the week about President Trump, causing many of his supporters to label the artist a “traitor.”

Aug 30 • 12:07 AM EDT • Politics • wavy.com

Was Dolly Parton a feminist? She wouldn’t say it, but fans heard it — in her life and her lyrics

Dolly Parton never embraced the feminist label, but her actions and lyrics spoke volumes.

Aug 29 • 12:03 AM EDT • Entertainment • ksat.com

Judge says Pentagon's measures against Anthropic were 'illegal and baseless'

The government labeled the company a supply chain risk earlier this year

Aug 28 • 8:14 AM EDT • Politics • spectrumlocalnews.com

Cath lab procedure kits recalled due to ongoing safety concern

The manifolds inside these kits have been linked to a significant risk of contamination. The FDA is urging users to place a warning label on each kit.

Aug 27 • 4:57 PM EDT • Business • cardiovascularbusiness.com

Adam and Eve store sues Fort Bend County over sexually oriented-business label

An Adam and Eve store in the Richmond area is suing Fort Bend County after being forced to register as a sexually-oriented business.

Aug 26 • 7:42 PM EDT • Business • abc13.com

Alleged Foldable iPhone Motherboard Photos Surface Online

Images and video claiming to show circuitry from Apple's upcoming foldable iPhone are circulating on X and Chinese social media platforms. For example, on X, the user "LusiRoy7" posted a short video alongside an image, as well as a labeled composite image identifying components, purportedly depicting the motherboard of Apple's foldable iPhone. The image appears to show the CPU, a hinge connector, a flex cable connector, and more.

Aug 26 • 7:33 AM EDT • Technology • macrumors.com

Cinq à Sept Built a $200 Million Business. Now It Wants Your Attention.

The 10-year-old label has built a thriving womenswear business that outsells buzzier competitors. Its next goal is to grab some of that buzz for itself.

Aug 26 • 12:30 AM EDT • Business • businessoffashion.com

Apple Quietly Refreshes Magic Keyboards

Apple today quietly introduced updated Magic Keyboard models with revised U.S. English key labeling. On the new keyboards, the tab, caps lock, shift, return, and delete keycaps are labeled with glyphs rather than edge text. On the full-size models with a numeric keypad, the change goes further, with the home, page up, page down, end, clear, and enter keys also swapping their text labels for symbols.

Aug 25 • 10:22 AM EDT • Technology • macrumors.com

Chaka Khan resists ‘straight icon’ label: ‘How do you know what the f--- I am?’

Chaka Khan pushed back against being labeled a ‘straight icon’ in a new interview: ‘How do you know what the f--- I am?’ she asked, adding, ‘I don’t ever share that part of my life.’

Aug 24 • 12:30 PM EDT • Entertainment • ew.com

Nate Bargatze Launches No Pictures, Sets Lawrence Grey To Oversee “Edgier” Production Label Alongside Family-Friendly Nateland Entertainment

EXCLUSIVE: After setting the Guinness World Record for most tickets sold on a stand-up tour, Nate Bargatze is continuing to expand his business — this time, in an unexpected direction. As he continues...

Aug 24 • 11:00 AM EDT • Entertainment • yahoo.com

Nate Bargatze Launches No Pictures, Hires Lawrence Grey In Exec Role

Nate Bargatze has launched No Pictures, hiring Lawrence Grey to oversee both Nateland and the new production label as Chief Content Officer.

Aug 24 • 11:00 AM EDT • Entertainment • deadline.com

As Democrats Struggle in Some Western States, Independents See an Opening

From South Dakota to Alaska, independents are challenging incumbent Republicans and eschewing a Democratic label that Western voters find toxic.

Aug 24 • 5:00 AM EDT • Politics • nytimes.com

Building the beat: How New Orleans can grow the business behind the music

People dance to the music of the TBC Brass Band Photo by Michael DeMocker / The Times-Picayune This week New Orleans hosts the annual Cutting Edge CE Conference, which brings together members of the music industry, musicians, lawyers and others to learn about and discuss the latest changes in the business of making, producing and selling music. googletag.cmd.push(function() { googletag.display('ad-1492300'); }); The conference comes as AI and streaming are causing upheavals in the industry. Meanwhile, we’ve seen at least a partial collapse of the global festival industrial complex which has long been a key financial lifeline for many artists.All of that can feel a bit removed from life in New Orleans. After all, we are a city filled with music. On any given day or night, there are dozens of shows across the city, ranging from jazz and blues to hip-hop, bounce and house. Whereas in other cities kids dream of being the star of their local sports team, in New Orleans more often than not they dream of leading their own band.And music is a huge part of our economy. Before New Orleans was known as a foodie destination, it was already drawing millions of visitors from around the globe to experience our jazz, soul and funk scenes firsthand.But the reality is, if you want to make it big, you’re probably going to end up leaving the city. We’ve seen major performers like Lil Wayne, Master P and Jon Batiste (though he’s back on the Northshore) decamp to Los Angeles, Miami and New York. Likewise, up-and-coming musicians like Greer Grimsely, $leazy EZ and Lucky Daye have also left town in search of more profitable pastures.Meanwhile, our local universities train some of the best producers and engineers in the business — only to see them head to one of the big music industry cities after graduation.It’s not a new phenomenon, though the reasons have changed over the years. Like a lot of early jazz musicians, Louis Armstrong famously left New Orleans, first for Chicago before ultimately settling in New York City. But while those early migrations had more to do with racism, in today’s day and age, musicians end up leaving because New Orleans doesn’t have the industry infrastructure necessary to sustain the kind of growth and, well, success, a lot of folks dream of.It’s a hard, but very real, truth. Artists have to go to Nashville for publishing, Los Angeles for production, Atlanta to join a label or New York for representation. That, in turn, is a drain not only on the city’s talent pool but on money that could be staying here at home.Not being an industry town inevitably makes it that much harder for musicians who don’t leave to get the recognition and success they deserve. It also undoubtedly plays a part in keeping the wages working musicians in New Orleans make at their gigs here lower than in places like Austin or Nashville.That’s not to say we don’t have any of the infrastructure needed to make New Orleans a music industry town. We’ve got live music venues, studios, record labels, management companies, copyright attorneys ... all the various building blocks are there. We just haven’t ever built upon that solid foundation. googletag.cmd.push(function() { googletag.display('ad-1492297'); }); The question is how do we do that in a way that supports our existing industry and artists, respects our cultural traditions and ensures the wealth generated is equitably distributed so it isn’t just C-suite executives who end up reaping the benefits. And the time to start figuring out the answers is now: next year the legislature will focus on taxes and spending, making it vital that New Orleans leaders have a plan to try and secure funding to help grow our industry.So we asked a group of New Orleanians to give us their thoughts, ranging from industry attorneys and venue operators to working musicians and cultural advocates. Their answers point toward turning New Orleans into a music industry city without leaving musicians behind or abandoning what makes us the greatest music city on earth.If a dusty city like Austin can transform itself into a major hub not just for music but the industry behind it, surely the birthplace of jazz — and pretty much all modern music by extension — can figure it out as well. +3 Mailbox Money: The Recording Academy’s Reid Wick on supporting, and growing, New Orleans’ music industry Reid Wick has been a part of the New Orleans music landscape from virtually every angle. He'… California Dreaming: Pell discusses his time in L.A. and how New Orleans can help young musicians In 2015, New Orleans-born rapper Pell decided to make the move to Los Angeles. He was fresh … +2 Up from the street: To build a stronger music industry, support community first. At MaCCNO, most of our team aren’t just advocates, we’re also working musicians. Here are a … +2 Live and direct: Public investment in independent venues is key to a robust music economy. I’ve spent most of my adult life looking at the New Orleans music business from every side o… +2 Helping Hand: New Orleans doesn’t need more talent. It needs more infrastructure. People love to call New Orleans a music town. And they’re right. +2 \We out here: New Orleans doesn't need to be Austin. It's already a music industry city. +2 Futureshock: New Olreans has the music talent. Now it needs the innovation. New Orleans has long been known as a place for music creation and innovation. People travel … .donate-gambit-article-module-container { text-align: center; padding: 10px; /* background-color: #24da6d; */ background-color: rgb(153, 0, 0); margin-bottom: 20px; } .donate-gambit-article-module-title { font-weight: bold; color: #fff; } .donate-gambit-article-module-copy { color: #fff !important; font-size: 16px; } .donate-gambit-article-module-button { background-color: black; width: 50%; border-color: black; font-size: 16px; } .donate-gambit-article-module-button:hover { background-color: black; } @media only screen and (max-width: 600px) { .donate-gambit-article-module-button { font-size: 14px; width: 100%; } .donate-gambit-article-module-copy { font-size: 14px; } } BECOME A GAMBIT MEMBER AND JOIN OUR KREWE TODAY For more than 40 years, Gambit has covered New Orleans, for New Orleans. We’ve stood up to city hall with you, cheered the Saints with you, danced in the streets with you and cried over our collective loss with you. And we’re plannin’ on being here for 40 more. To do that, we need your help. Become a Gambit member today and help us continue our mission SUPPORT GAMBIT

Aug 23 • 9:00 AM EDT • Business • nola.com

Janie Bradford Dies at 87: The Songwriter Who Helped Build the Motown Sound

Janie Bradford helped build Motown from its earliest days, co-writing enduring hits, working with some of the label’s biggest stars and later investing in the next generation of performers.

Aug 23 • 6:00 AM EDT • Entertainment • yahoo.com

DECISION 2026: Political labels are everywhere in 2026 campaigns. But what do they actually tell voters?

WEAU political analyst John Frank says much of today’s political labeling is campaign strategy as Pew research shows voters’ beliefs are more complicated than red versus blue.

Aug 23 • 3:45 AM EDT • Politics • weau.com

Are Dried and Frozen Fruits as Healthy as Fresh Fruits? A Nutritionist Weighs In

Frozen and dried fruits can be just as nutritious as fresh fruit. However, it’s important to check the nutrition labels for added sugars.

Aug 22 • 8:00 AM EDT • Health • health.com

Why 'science-backed' is becoming an important label in wellness

Social media is the go-to place for wellness content today. Influencers promote everything from health tips to supplements and provide education on numerous health issues. Wellness content has even led viewers to seek help or get a diagnosis. However, wellness content is largely riddled with misinformation and conflicting advice. Influencers are encouraged to make

Aug 21 • 4:19 AM EDT • Science • kvia.com

Apple Music will soon get visible labels for AI-generated content

Apple has shared more details about the AI labeling requirements it announced for Apple Music back in March. Here are the details.

Aug 20 • 4:08 PM EDT • Technology • 9to5mac.com

Patriots’ New WR Corps Backs Up ‘Significant Talent Upgrade’ Label

The New England Patriots assembled a receiving corps that looks capable of becoming one of the NFL’s deepest.PFF gave the Philadelphia Eagles the edge, though.PFF ranked Philadelphia No. 8 and New England No. 9 among all 32 receiving corps entering 2026, putting the Patriots one spot behind the team that traded them A.J. Brown in […] The post Patriots’ New WR Corps Backs Up ‘Significant Talent Upgrade’ Label appeared first on HEAVY.

Aug 20 • 3:01 PM EDT • Sports • sports.yahoo.com

10th Street Entertainment Launches 'Pub Crawl' Label And Publishing Divisions, Adds Piero Giramonti As EVP & Artist Manager

Major artist management company 10th Street Entertainment has launched its own Pub Crawl Recordings label group and Pub Crawl Songs music publishing company,

Aug 20 • 1:35 PM EDT • Entertainment • news.pollstar.com

Miyazaki Says The Duskbloods Reveal Probably Gave Fans The Wrong Impression

"The PvPvE [label is] a little bit confusing in the context of this game."

Aug 20 • 10:00 AM EDT • Technology • gamespot.com

Peggy Flanagan isn’t a democratic socialist. But here’s where she agrees, and doesn’t, with the DSA

Flanagan has rejected the democratic socialist label even as Republicans try to pin it on her.

Aug 20 • 7:00 AM EDT • Politics • startribune.com

All 6 NCT Dream members renew contract with SM Entertainment

NCT Dream’s remaining six members all extended contracts with SM Entertainment, the label said in a statement issued Thursday. Haechan signed a renewal last mon

Aug 19 • 10:10 PM EDT • Entertainment • koreaherald.com

Apple's Camera AirPods May Launch as 'AirPods Pro,' Not 'AirPods Ultra'

The camera-equipped AirPods that we've confirmed Apple is working on are likely going to be part of the AirPods Pro lineup rather than separate "AirPods Ultra". A macOS Tahoe 26.7 file that references the new AirPods is labeled "AirPods Pro," hinting at the new name.

Aug 18 • 2:01 PM EDT • Technology • macrumors.com

Walter’s insurer to slash scrutinized loans by $6.5 billion

The move whittles down the more than $20 billion of loans that insurers controlled by Walter previously said should have been labeled as affiliated but weren’t.

Aug 18 • 11:17 AM EDT • Business • chicagobusiness.com

Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start

By Angela Hart and KFF Health News HealthDay ReportersTUESDAY, Aug. 18, 2026 (HealthDay News) — At a Walgreens in San Francisco’s bustling Japantown neighborhood, pharmacist Margaret On stocks two boxes of long-acting insulin pens from California’s new prescription drug label, CalRx, emblazoned ...

Aug 18 • 5:30 AM EDT • Health • usnews.com

BUSINESS ‘Punk, intense and all-encompassing’: Chicagoan Dawn Heilung brings trans artists into focus

Gender Fucked Productions (Gender Fucked) Founder and former Executive Director and Artistic Director Dawn Heilung uses many labels to describe themselves— queer, bisexual, pansexual, polyamorous, trans, non-binary, transfeminine—because “I don’t think one can fully encompass my experience.” “I started [the trans, enby and queer arts and event production focused nonprofit] Gender Fucked Productions in 2022 because […]

Aug 16 • 9:24 PM EDT • Business • windycitytimes.com

AI needs science’s search history

“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.

Aug 13 • 11:16 AM EDT • Science • press.airstreet.com

'iPhone Ultra' Could Face Staggered Country Rollout Like Vision Pro

Apple's foldable "iPhone Ultra" may get a Vision Pro-style staggered country-by-country launch over several months, with initial availability limited to the U.S. market, according to an Australian publication. In a report labeled "exclusive," ChannelNews said today it has been told by local carriers and one major retailer that Apple's first foldable iPhone will be a "no show" when the iPhone 18 Pro models launch in September, despite being unveiled together.

Aug 13 • 8:56 AM EDT • Technology • macrumors.com

The US is now using the ‘terrorist’ label to interfere in Brazil’s election

The designation of PCC and CV serves to expand Washington’s reach into the country’s politics and security.

Aug 13 • 2:33 AM EDT • Politics • aljazeera.com

David Crowley rejects ‘establishment’ label after upset in Wisconsin primary

Aug 12 • 9:37 PM EDT • Politics • cnn.com

Excel Entertainment and Universal Music’s sub-label Excel Music is here

In January, the Universal Music Group announced that it had acquired a 30% stake in Excel Entertainment, the Indian production house behind such hit Bollywood movies and soundtracks as Dil […]

Aug 12 • 6:20 AM EDT • Entertainment • musically.com

Testing finds 85% of everyday personal care products contain unlabeled chemicals with suspected health hazards

A new study of sunscreens, baby lotions, shampoos, soaps and other everyday products found that nearly all contained chemicals not disclosed on their labels. Most contained at least one unlabeled chemical ...

Aug 11 • 3:40 PM EDT • Health • medicalxpress.com

The U.S. Healthcare System is Already Mostly Socialized

Now that Abdul El-Sayed is the Democratic nominee for Michigan’s open Senate seat, the outcome of this crucial race will depend mainly on two things: Whether Republicans succeed in demonizing El-Sayed because he’s brown and a Muslim, and whether they succeed in demonizing him as a left-wing radical. I will defer for the now the question of whether bigotry will be effective this year, although I will address it another day. What I want to address instead is El-Sayed’s signature issue — healthcare. Yes, El-Sayed advocates Medicare for All, a position the usual suspects denounce as “socialism.” I will get to the politics of his stance soon. Today, however, I want to talk about the substance. We should be clear that El-Sayed doesn’t even call himself a socialist. On the contrary, he explicitly disavows the label, saying “I’m a capitalist who just knows about capitalism”. In fact, as I explained in a previous post, the policies that El-Sayed advocates qualify him as a social democrat, not a socialist. Still, El-Sayed advocates a system under which the government would pay almost all medical expenses. Isn’t that socialism? Well, if that is the criterion then much of U.S. healthcare is already socialist. In fact, the government’s role is so large that U.S. healthcare is better described as partially privatized socialism than as anything resembling a free market. Let’s start with the raw numbers on health insurance, which pays the bulk of Americans’ medical expenses. Americans receive health insurance either from private companies or from public programs, overwhelmingly Medicare and Medicaid. Here’s what the breakdown of coverage and spending between private and public looked like in 2024: While a majority of Americans with health insurance get it from private companies, well over 100 million of us are covered by government programs instead. And these government programs pay more total dollars for medical bills than the private insurers do. Why do government programs that cover a minority of the population account for a majority of health insurers’ outlays? Mainly because Medicare covers seniors, and we’re expensive. Also, while Medicaid covers many younger Americans, disabled and elderly beneficiaries account for most of its spending. Even by the raw numbers, then, U.S. health insurance looks as much public as private. But that understates the government’s role: Private health insurance in the U.S. is both highly regulated and heavily subsidized. This is obviously true for the insurance coverage purchased by tens of millions of Americans through the exchanges established by the Affordable Care Act. But employment-based health insurance, which covers 161 million Americans, is far more of a government creation than most people realize. For employment-based insurance exists largely because of huge implicit government subsidies that come with major strings attached. Here’s how that works. If your employer pays you $10,000, that’s taxable income. But if your employer pays $10,000 toward a company health insurance plan that meets certain criteria, it isn’t taxable. That’s a huge effective subsidy, running at more than $300 billion a year. Take that subsidy into account, along with the more than $100 billion per year spent subsidizing policies purchased under the ACA, as well as the outlays on Medicare and Medicaid, and net effect is that the government pays for more than two-thirds of Americans’ health insurance. Granted, there are strings attached. Roughly speaking, employment-based health plans can’t discriminate based on medical history — that is, they can’t deny coverage to employees with pre-existing conditions — and they also can’t offer the plans only to highly compensated employees — a health plan that is only for the C-suite is considered taxable income. So given the restrictions of the federal tax code, employer-based health insurance is a lot like Obamacare, which also prohibits discrimination based on medical history and provides subsidies to make insurance affordable to lower-paid workers. The fact is that virtually all of private healthcare insurance is already well under some form of government control through regulation and tax subsidies. How should we think about this system? First of all, is Medicare socialist? Don’t tell anyone, but the way Medicare operates — it covers every senior’s medical expenses, whatever they turn out to be, while being funded by taxes that depend on one’s income — could be summarized by the old Marxist slogan “From each according to his ability, to each according to his need.” And back in 1961, when Ronald Reagan was the face of a last-ditch effort by the American Medical Association to block the creation of Medicare, he denounced Medicare as “socialized medicine” and warned that it would destroy our freedom. In reality, American freedom survived until Jan. 20, 2025, while Medicare is immensely popular, with an 82 percent favorable rating in the most recent KFF survey. Medicaid, government health insurance for lower-income Americans, comes in at 73 percent. This is in sharp contrast to public views about private insurers, who are widely disliked if not hated and accused of denying essential care. Furthermore, if Medicare is socialism, then the whole U.S. health insurance system, with the government paying most of the bills and placing conditions on private insurers, is almost equally socialist. If you insist on calling any program the government pays for and regulates socialist, then U.S. healthcare would best be described as a partially privatized form of socialism. And one must ask, what is the point of the part that is privatized? Do private insurers add anything positive? Or are they simply parasites, skimming off money that could have been paying for care? The case for viewing insurers as parasites is strong. Many Medicare benefits are now delivered via Medicare Advantage, that is, plans paid for by the government but run through insurance companies. MedPAC, an independent advisory commission, estimates that last year Medicare Advantage plans were overpaid by $84 billion, thanks to practices such as “upcoding,” in which patients’ health problems are overstated to get larger sums from Medicare. Assessing the waste from employer-based insurance is harder, but most evidence suggests that private insurers have substantially higher administrative costs than Medicare does. Furthermore, the complexity of private insurance, with multiple payers all trying to deny care when they can, is a huge burden both on providers — doctors, nurses, and hospitals — and on patients. What do private insurers offer to compensate for these costs? One must go through intellectual contortions to avoid the conclusion that they are, in fact, parasites. Which brings me back to El-Sayed. In supporting Medicare for All, he’s basically calling for an end to the partial, parasitic privatization of a healthcare system that is already hugely dependent on public funding. When one looks at it that way, it’s not at all a radical proposal. Admittedly, the political lift requires overcoming the opposition to higher taxes to pay for Medicare for All. Political realism rather than economics was the reason I and many other progressives supported Obamacare, with all its complexities, rather than demanding an immediate move to Medicare for All. But the political calculus may very well have shifted since the 2000s, as Americans are fed up with a system of unaffordable premiums, rampant claim denials, and byzantine claim administration. Moreover, funding healthcare insurance through taxation would allow for a much more progressive distribution of the cost. That is, compared to the present system, middle-income households would pay less as high-income households would pay more. And the U.S. would stop wasting large sums on pointless administrative costs. So let’s be clear: El-Sayed’s healthcare platform is perfectly reasonable on the merits of cost, fairness and health efficacy. And with private insurers never more hated, while millions of Americans are losing their health insurance, 2026 may be its time. MUSICAL CODA

Aug 11 • 6:33 AM EDT • Health • paulkrugman.substack.com

Celtics Newcomer Named X-Factor After Blockbuster Jaylen Brown Trade

The Celtics’ return for Jaylen Brown enters next season carrying an X-factor label and the pressure to keep Boston among the East’s elite. The post Celtics Newcomer Named X-Factor After Blockbuster Jaylen Brown Trade appeared first on HEAVY.

Aug 10 • 8:16 PM EDT • Sports • sports.yahoo.com